Thyrotoxicosis with diffuse goiter
ICD-10 E05.0 is a billable code used to indicate a diagnosis of thyrotoxicosis with diffuse goiter.
Thyrotoxicosis with diffuse goiter is a condition characterized by an excess of thyroid hormones in the bloodstream, often resulting from hyperactivity of the thyroid gland. This condition is commonly associated with Graves' disease, an autoimmune disorder that leads to the overproduction of thyroid hormones and the enlargement of the thyroid gland, known as goiter. Patients may present with symptoms such as weight loss, increased appetite, anxiety, tremors, heat intolerance, and palpitations. The diffuse goiter indicates that the enlargement of the thyroid gland is uniform rather than nodular. Diagnosis typically involves clinical evaluation, thyroid function tests, and imaging studies. Thyroid function tests measure levels of Thyroid Stimulating Hormone (TSH), Free T4, and Free T3, which are crucial for confirming hyperthyroidism. Management may include antithyroid medications, radioactive iodine therapy, or surgical intervention, depending on the severity and underlying cause of the thyrotoxicosis.
Thorough documentation of thyroid function tests, imaging results, and treatment plans.
Patients presenting with symptoms of hyperthyroidism, routine follow-ups for thyroid management, and pre-operative evaluations for thyroid surgery.
Endocrinologists must ensure that all relevant lab results and clinical findings are documented to support the diagnosis and treatment plan.
Detailed patient history, physical examination findings, and referrals to specialists if necessary.
Initial evaluation of patients with symptoms of hyperthyroidism and management of mild cases.
Primary care providers should document any referrals and follow-up care to ensure continuity of care.
Used to evaluate thyroid function in patients suspected of having thyrotoxicosis.
Document the reason for the test and any relevant clinical findings.
Endocrinologists may require additional tests to confirm diagnosis.
Common symptoms include weight loss, increased appetite, anxiety, tremors, heat intolerance, and palpitations. Patients may also experience fatigue and muscle weakness.
